Skip to main content
HairCited

Medical and procedural treatment of androgenetic alopecia - Where are we?

Nathalie Y Ly, Sophia Fruechte, Maria K Hordinsky, Neil Sadick, Suleima Arruda et al.
Review Journal of the American Academy of Dermatology 2023 20 citazioni
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D37591565'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Tipo di studio
Review
Popolazione
Patients with androgenetic alopecia
Intervento
Medical and procedural treatment of androgenetic alopecia - Where are we? LDOM, finasteride, PRP, photobiomodulation
Comparatore
None
Esito primario
AGA treatment advances overview
Direzione dell'effetto
Positive
Rischio di bias
Unclear

Abstract

Novel medical and procedural options for androgenetic alopecia have arrived. Low-dose oral minoxidil has made its clinical debut, while data on spironolactone, finasteride, and nutritional supplements have advanced. Minimally invasive technological advancements include photobiomodulation and platelet-rich plasma. Within hair transplantation, follicular unit extraction and robotics are now at the clinicians' fingertips.

TL;DR

None

Used In Evidence Reviews

Similar Papers